Yaakov Dickstein

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni et al. · The Lancet Infectious Diseases · 2018 · 593 citations

Severe Infections, Health Sciences, Antibiotics +9

Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial

Dafna Yahav, Erica Franceschini, Fidi Koppel et al. · Clinical Infectious Diseases · 2018 · 387 citations · Full text

Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial

Mical Paul, Jihad Bishara, Dafna Yahav et al. · BMJ · 2015 · 151 citations · Full text

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial

Yaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar et al. · Clinical Infectious Diseases · 2018 · 119 citations

Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers

Yaakov Dickstein, Ravit Edelman, Tali Dror et al. · Journal of Hospital Infection · 2016 · 105 citations

Ill Patients, Healthcare-associated Infection, Hospital Epidemiology +6